Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus

Inclusion Criteria: * Males, ages 20 to 80-years-old, inclusive * A diagnosis of type 2 diabetes mellitus by American Diabetes Association (ADA) criteria for at least 6 months * Treatment with a stable but sub-optimum dose of OHAs for at least 2 months prior to screening based on a lack of control of blood glucose * Previous diagnosis of adult-onset idiopathic hypogonadotropic hypogonadism (AIHH) and have undergone treatment with a topical testosterone gel, Low-to-borderline morning total testosterone (TT), after at least a two week wash-out period, and normal or low normal serum luteinizing hormone (LH)at screening and at baseline * No previous diagnosis of AIHH but present as naïve patients with low morning TT and normal or low normal serum LH at screening and at baseline * Body Mass Index (BMI) between 26 and 40 kg/m2 * Fasting blood (plasma or serum) glucose (FBG) between 125 and 240 mg/dL * HemoglobinA1c in serum as (HbA1c) between 7% and 9.5% * Comprehends informed consent * Otherwise normal healthy males * All clinical laboratory test within normal ranges (any deviation outside the normal range will require approval of investigator) * Ability to complete the study in compliance with the protocol * Ability to understand and provide written informed consent Exclusion Criteria: * A history of testicular failure, Kallmann Syndrome or other infertility condition * Clinically significant medical condition rendering the subjects infertile including tumors of the pituitary,…